Loading...
XTAI
1598
Market cap104mUSD
Oct 08, Last price  
20.10TWD
1D
-0.74%
1Q
5.24%
Jan 2017
-48.88%
IPO
-35.21%
Name

Dyaco International Inc

Chart & performance

D1W1MN
XTAI:1598 chart
P/E
—
P/S
0.55
EPS
—
Div yield, %
2.49%
Shrs. gr., 5y
6.98%
Rev. gr., 5y
-14.15%
Revenues
6.12b
-15.19%
2,460,194,0004,984,988,0002,947,783,0002,807,835,0003,724,553,0004,764,365,0004,415,214,0004,724,842,0004,457,716,0005,557,150,0005,850,528,00013,123,756,00011,742,081,0007,122,411,0007,786,471,0007,217,077,0006,121,041,000
Net income
-561m
L
32,203,000177,818,000112,500,00024,484,00023,605,000273,553,000253,702,000301,361,000-150,891,000107,123,000189,001,0001,321,109,000440,342,000-94,683,000-122,770,00071,952,000-561,449,000
CFO
-397m
L
83,100,000303,896,000177,308,000-253,306,000428,239,000575,867,000220,781,000603,375,000-238,556,000-44,734,000411,747,0001,277,086,000-781,464,000626,766,000619,022,000492,260,000-397,434,000
Dividend
Jun 30, 20260.5 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Dyaco International Inc., headquartered in Taipei City, Taiwan since its establishment in 1990, operates globally in the design, manufacturing, and distribution of fitness, physical therapy, and sports equipment. The company's diverse product range features cardiovascular machines for residential, commercial, and medical applications, in addition to dedicated indoor cycling solutions. It supplies its exercise apparatus to a wide clientele, including individual consumers, commercial gym operators, and rehabilitation centers, under prominent brands such as Spirit Fitness, Xterra, SOLE Fitness, Johnny G, Dyaco Medical, and UFC.

Key people

Youying Lin
Chairman of the Board · since 2023
Mei-Hua Wu
Chief Financial Officer, Executive Deputy General Manager · since 1998
Yu-Hsiang Tseng
Chief Operating Officer · since 2022
Brian Murray
Chief Technology Officer · since 2008
Yuan-Sheng Chiu
Chief Accounting Officer, Deputy General Manager-Finance Division, Chief Corporate Governance Officer · since 2013
Ming-Nan Chen
General Manager · since 2017
Song-Guo Chen
Deputy General Manager-Domestic Business Domestic Business · since 2024
Li-Wen Hsu
Deputy General Manager-Sales Division · since 1999
Yu-Chih Huang
Deputy General Manager-Sales Division · since 2013
Hsuan-Fu Huang
Deputy General Manager-R&D Division · since 1997
Chi-Jung Li
Executive Deputy General Manager · since 2014
Shih-Chieh Lin
Deputy General Manager-Medical Rehabilitation Division · since 2013
Teng-I Lo
Deputy General Manager-Production Division · since 2017
Ping-I Ting
Chief Strategy Officer · since 2023
Director · since 2023
Zhu-Wei Zhuang
Director · since 2020
Independent Director · since 2023
Independent Director · since 2011
Chih-Cheng Wang
Independent Director · since 2017
Jiin-Po Wu
Independent Director · since 2023
IPO date
Oct 24, 2011
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT